iDXGate TO overcomes the limitations of existing diagnostic methods through unique self-developed CTC* capture technology. With iDXGate TO, you can make quick treatment choices, and it increases the accuracy of early recurrence diagnosis, improves monitoring convenience, and enhances prognostic prediction accuracy. Due to broad analysis range, it allows confirmation of genetic, RNA expression, and protein profile changes. *CTC: circulating tumor cell